Henlius | 复宏汉霖 logo

Henlius | 复宏汉霖 Employee Directory

Biotechnology ResearchShanghai, China501-1000 Employees

Henlius is a Shanghai-based biopharmaceutical company that develops, manufactures, and distributes oncology therapies. Drawing on experience across the pharmaceutical industry, its team works to deliver treatments that are both clinically effective and more affordable for patients in about 60 countries. The company focuses on oncology and other diseases with the aim of helping people regain healthy lives. Through its development and manufacturing activities, Henlius supports a growing portfolio in biotechnology.

In April 2024, Henlius and Organon announced positive results from a phase 3 trial of HLX14, a denosumab biosimilar to Prolia and Xgeva, which met its primary endpoints. The same announcement described a license and supply agreement granting Organon exclusive commercialization rights to two denosumab biosimilar candidates. These developments reflect the company’s ongoing collaboration with global partners to advance oncology biosimilars.

Find Henlius | 复宏汉霖 employees' phone numbers or email addresses

Henlius | 复宏汉霖 Global Highlights

Location
Employees

Asia
281

Minus sign iconPlus sign icon
  • China
    274
  • Singapore
    4
  • Japan
    3

North America
20

Minus sign iconPlus sign icon
  • United States Of America
    19
  • Canada
    1

Europe
6

Minus sign iconPlus sign icon
  • Switzerland
    3
  • France
    1
  • Germany
    1
  • Poland
    1

Oceania
4

Minus sign iconPlus sign icon
  • Australia
    4

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Henlius | 复宏汉霖's Leadership

  • Stylized image of a person
    J. Z.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    D. P.
    Chief Commercial Officer, International Markets
    Phone icon
  • Stylized image of a person
    J. Y.
    Chief Scientific Officer
    Phone icon
  • Stylized image of a person
    V. Z.
    Chief Officer, Chairman Office
    Phone icon
  • Stylized image of a person
    K. Y.
    Vp Of Marketing & Commercial Operation
    Phone icon
  • Stylized image of a person
    J. L.
    Vice President Regulatory Affairs
    Phone icon
  • Stylized image of a person
    L. Q.
    Head Of Compensation & Benefits
    Phone icon
  • Stylized image of a person
    W. Z.
    Chairman And Ceo
    Phone icon

Henlius | 复宏汉霖 Employee Metrics

100%
50%
0%
2026
2025
  • Administrative
  • Biotechnology
  • Business
  • Legal
  • Human Resources
  • Other
  • Program & Project Management

Contact profiles from Henlius | 复宏汉霖

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    D. P.
    Chief Commercial Officer, International Markets
    Phone icon
    SwitzerlandGeneva
    Jul 07, 2026
  • Stylized image of a person
    J. Y.
    Chief Scientific Officer
    Phone icon
    Hong Kong
    Jul 13, 2026
  • Stylized image of a person
    J. Z.
    Chief Executive Officer
    Phone icon
    ChinaShanghai
    Jul 13, 2026
  • Stylized image of a person
    V. Z.
    Chief Officer, Chairman Office
    Phone icon
    ChinaShanghai
    Oct 24, 2025
  • Stylized image of a person
    W. Z.
    Chairman And Ceo
    Phone icon
    ChinaShanghai
    Jul 13, 2026
  • Stylized image of a person
    C. Z.
    Vp, Data Science Center 数据科学中心副总裁
    Phone icon
    ChinaBeijing
    Jul 13, 2026
  • Stylized image of a person
    K. Y.
    Vp Of Marketing & Commercial Operation
    Phone icon
    ChinaShanghai
    Jul 22, 2026
  • Stylized image of a person
    R. L.
    Director, Head Of Frontier Drug Discovery
    Phone icon
    AustraliaVictoria
    Jul 13, 2026
  • Stylized image of a person
    J. L.
    Vice President Regulatory Affairs
    Phone icon
    ChinaBeijing
    Jul 13, 2026
  • Stylized image of a person
    L. Q.
    Head Of Compensation & Benefits
    Phone icon
    ChinaShanghai
    May 09, 2026

Frequently Asked Questions

What is Henlius | 复宏汉霖 known for?

Minus sign iconPlus sign icon
Henlius | 复宏汉霖 was founded in 2010 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore Henlius | 复宏汉霖's company overview page for more information.

What is Henlius | 复宏汉霖's most common email format?

Minus sign iconPlus sign icon
Henlius | 复宏汉霖 employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Henlius | 复宏汉霖 email formats with LeadIQ.

How many employees does Henlius | 复宏汉霖 have currently?

Minus sign iconPlus sign icon
Henlius | 复宏汉霖 has approximately 509 employees as of July 2026. These team members are located across 5 continents, including AsiaNorth AmericaEurope.

Who are Henlius | 复宏汉霖's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Henlius | 复宏汉霖's key employees include:

  • Chief Executive Officer: J. Z.
  • Chief Commercial Officer, International Markets: D. P.
  • Chief Scientific Officer: J. Y.
  • Chief Officer, Chairman Office: V. Z.
  • Vp Of Marketing & Commercial Operation: K. Y.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.